|
Schmid, H., Delgrande Jordan, M., Kuntsche, E. N., & Kuendig, H. (2003). Trends im Konsum psychoaktiver Substanzen von Schülerinnen und Schülern in der Schweiz : ausgewählte Ergebnisse einer Studie durchgeführt unter der Schirmherrschaft der Weltgesundheitsorganisation (WHO). Lausanne: Schweizerische Fachstelle für Alkohol- und andere Drogenprobleme (SFA).
Keywords: addiction; AOD dependence; chemical addiction
|
|
|
sda. (2001, 01.02.2001). Treffpunkt für Alkoholabhängige : Pilotversuch des Sozialdepartements. Neue Zürcher Zeitung, 1.
Keywords: addiction; AOD dependence; chemical addiction; alcohol; alcoholic; harm reduction; zurich
|
|
|
Muscat, R., & of the Pompidou Group Treatment Platform, M. (2009). Treatment systems overview (T. Agard, C. Lahmek, S. Bazarya, R. Muscat, & G. Welle-Strand, Eds.). Paris: Pompidou Group; Council of Europe.
Keywords: treatment and maintenance
|
|
|
Dore, G. J., Hellard, M., Matthews, G., Grebely, J., Haber, P. S., Petoumenos, K., et al. (2009). Treatment of recent hepatitis C virus infection in a predominantly injection drug user cohort : the ATAHC study. In 1st International Symposium on Hepatitis care in substance users (24). Zurich: University of New South Wales (UNSW), National Centre in HIV Epidemiology and Clinical Research; St Vincent's Hospital, HIV/Immunology/Infectious Diseases Clinical Services Unit; Burnet Institute; The Alfred Hospital, Infectious Diseases Unit; Royal Pri.
Keywords: hepatitis C; intravenous drug user; medical treatment method; Australia
|
|
|
Kolar, A. F., Brown, B. S., Weddington, W. W., Haertzen, C. C., Michaelson, B. S., & Jaffe, J. H. (1992). Treatment of cocaine dependence in methadone maintenance clients : a pilot study comparing the efficacy of desipramine and amantadine. International journal of the addictions, 27(7), 849–868.
Abstract: We conducted a pilot study (N = 22) comparing the efficacy of desipramine and amantadine for treatment of cocaine dependence in methadone maintenance clients. The study which lasted 12 weeks, was double-blind, randomly assigned, and placebo-controlled. Subjects met DSM-III-R criteria for active cocaine dependence. All three groups’ cocaine use, craving, and depressive symptoms declined significantly, but intergroup differences were not significant. Clients receiving desipramine were significantly more likely to remain in treatment and to be cocaine free at study completion. The results emphasize the importance of delivering comprehensive services to the cocaine user in methadone treatment. Further evaluations of these two medications as adjuncts in the treatment of cocaine dependence are needed.
Keywords: addiction; AOD dependence; chemical addiction; cocaine
|
|
|
Schaefer, M. (2009). Treatment of chronic Hepatitis C in patients with psychiatric disorders. In 1st International Symposium on Hepatitis care in substance users (57). Zurich: Kliniken Essen-Mitte, Klinik für Psychiatrie, Psychotherapie und Suchtmedizin; Universitätsmedizin Berlin, Campus Charité Mitte, Klinik für Psychiatrie und Psychotherapie.
Keywords: hepatitis C; AOD abuse; intravenous drug user; behavioral and mental disorder; medical treatment method; treatment and maintenance
|
|
|
Dalgard, O., Bjøro, K., Hellum, K., Myrvang, B., Skaug, K., Gutigard, B., et al. (2002). Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years' Follow-Up. European addiction research, 8, 45–49.
Abstract: Aim of the Study: To assess the long-term hepatitis C (HCV) treatment outcome in former injecting drug users (IDUs). Materials and Methods: A long-term follow-up of 27 former IDUs who had been successfully treated for chronic hepatitis C was performed. These patients represented ailiDUs who had obtained a sustained virological response in a Norwegian HCV treatment trial. The patients had been treated with interferon-a alone or in combinatlon with ribavirin. At 5 years’ follow-up the 27 IDUs were retested for HCV RNA and risk behaviour for HCV transmission after treatment was assessed. In the control group ail 18 non-IDUs who had obtained a sustained virological response in the same treatment trial were included. Results: At follow-up 13-82 months (median 64) after the end of treatment only one case of probable reinfection was seen among the 27 IUDs. No reoccur- rence of HCV was observed in the control group. The IDU who was HCV RNA positive at follow-up had continued injecting drugs and reported frequent needle sharing. At follow-up HCV of genotype 1a was detected in contrast to genotype 1b before treatment indicating that this patient was reinfected with HCV. A return to injecting drug use occurred in 9 (33%) of 27 IDUs. Conclusion: The long-term outcome of HCV treatment in former IDUs was excellent. Despite frequent reinitiation of drug injection ail but 1 remained HCV RNA negative.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
Davis, G. L., & Rodrigue, J. R. (2001). Treatment of chronic hepatitis C in active drug users. The New England journal of medicine, 345(3; 19.07.2001), 215–217.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
Seller, C. (2001). Treatment Denied : Inmates and Hepatitis C. Harm Reduction Communication, 11, 14–16.
Keywords: health promotion; viral hepatitis; hepatitis C
|
|
|
Montanari, L., Guarita, B., Noor, A., Wiessing, L., Gomes, F., Hedrich, D., et al. (2012). Treatment demand indicator (TDI) : standard protocol 3.0 : guidelines for reporting data on people entering drug treatment in European countries (European Monitoring Centre for Drugs and Drug Addiction, Ed.). Manuals, 9. Luxembourg: Publications Office of the European Union.
Abstract: This Manual is a revised edition of the Treatment demand indicator (TDI) protocol version 2.0 and presents updated guidelines for reporting data on people entering drug treatment in Europe. The TDI is one of five key epidemiological indicators which provide a common European methodology for collecting and reporting core data on the number and profiles of those entering specialised drug treatment each year. TDI data are routinely used in EMCDDA analysis of the drug situation in Europe, helping to identify trends and patterns in problem drug use and to assess the use and uptake of treatment facilities.
Keywords: addiction; harm reduction; treatment and maintenance; heroin-assisted treatment; methadone; quality control; recommendations or guidelines; database; international area; Europe; report
|
|